- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04300777
The Fixation Study
March 30, 2023 updated by: SeaSpine, Inc.
Clinical Evaluation of the SeaSpine Non-Cervical Pedicle Screw Systems
To perform a clinical evaluation of safety and performance for the SeaSpine Non- Cervical Pedicle Screw Systems
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Detailed Description
A multi-center, post-market, clinical evaluation for subjects implanted with the SeaSpine Non-Cervical Pedicle Screw Systems
Study Type
Observational
Enrollment (Actual)
50
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Michigan
-
Jackson, Michigan, United States, 49201
- Henry Ford
-
-
Ohio
-
New Albany, Ohio, United States, 43054
- OrthoNeuro
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients who have been implanted with a SeaSpine Non-Cervical Pedicle Screw System
Description
Inclusion Criteria:
- Have undergone surgery
- Have undergone at least 12-months of postoperative follow-up
Exclusion Criteria:
- Any condition that the Investigator determines is unacceptable
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Treated with Non-Cervical Pedicle Screw Systems
50 patients who have been implanted with SeaSpine Non-Cervical Pedicle Screw Systems
|
Any patient treated with a SeaSpine Non-Cervical Pedicle Screw System
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The primary outcome for the study is device performance.
Time Frame: 12 months post-operative
|
Device performance is defined as lack of component failure involving screw and/or rod fracture and/or screw loosening or disassociation.
|
12 months post-operative
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluation of unanticipated adverse device effects (UADE)
Time Frame: 12-months
|
Intra or Post-Procedure UADEs
|
12-months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Frank Vizesi, Ph.D., SeaSpine, Inc.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 5, 2020
Primary Completion (Actual)
June 30, 2021
Study Completion (Anticipated)
June 30, 2023
Study Registration Dates
First Submitted
March 5, 2020
First Submitted That Met QC Criteria
March 6, 2020
First Posted (Actual)
March 9, 2020
Study Record Updates
Last Update Posted (Actual)
April 4, 2023
Last Update Submitted That Met QC Criteria
March 30, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SS-PMCF-1905
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.